Evidence map›Paper›PMID 25422944›Full record

ArticlePloS one2014

The insulin/IGF signaling regulators cytohesin/GRP-1 and PIP5K/PPK-1 modulate susceptibility to excitotoxicity in C. elegans.

Nazila Tehrani, John Del Rosario, Moises Dominguez, Robert Kalb, Itzhak Mano

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Nazila TehraniPhysiology Pharmicology & Neuroscience, Sophie Davis School of Biomedical Education, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America; Graduate Program in Neurobiology, The Graduate Center, The City University of New York (CUNY), New York, New York, United States of America.
John Del RosarioPhysiology Pharmicology & Neuroscience, Sophie Davis School of Biomedical Education, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America; MA Program in Biology, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America.
Moises DominguezPhysiology Pharmicology & Neuroscience, Sophie Davis School of Biomedical Education, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America; Undergraduate Program in Biology, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America.
Robert KalbNeuroscience Graduate Group, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Itzhak ManoPhysiology Pharmicology & Neuroscience, Sophie Davis School of Biomedical Education, City College of New York (CCNY), The City University of New York (CUNY), New York, New York, United States of America; Graduate Program in Neurobiology, The Graduate Center, The City University of New York (CUNY), New York, New York, United States of America.
City College of New York · USCity University of New York · USThe Graduate Center, CUNY · USUniversity of Pennsylvania · US

Funding

TNC FUNCTION IN APOPTOTIC ANTIGEN DRIVEN AUTOIMMUNITYG12RR003060 · NCRR · CITY COLLEGE OF NEW YORK · PI STAIANO-COICO, LISA F · 1985 to 2011
$26.1M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
RESEARCH SUPPORT FOR BIOMEDICAL CAREERS AT CCNYR25GM056833 · NIGMS · CITY COLLEGE OF NEW YORK · PI STEINBERG, MARK L · 2000 to 2019
$9.9M
NCRR NIH HHS 5G12RR003060-26NCRR NIH HHS G12 RR003060NIGMS NIH HHS R25 GM056833NIMHD NIH HHS 8G12MD7603-28NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

During ischemic stroke, malfunction of excitatory amino acid transporters and reduced synaptic clearance causes accumulation of Glutamate (Glu) and excessive stimulation of postsynaptic neurons, which can lead to their degeneration by excitotoxicity. The balance between cell death-promoting (neurotoxic) and survival-promoting (neuroprotective) signaling cascades determines the fate of neurons exposed to the excitotoxic insult. The evolutionary conserved Insulin/IGF Signaling (IIS) cascade can participate in this balance, as it controls cell stress resistance in nematodes and mammals. Blocking the IIS cascade allows the transcription factor FoxO3/DAF-16 to accumulate in the nucleus and activate a transcriptional program that protects cells from a range of insults. We study the effect of IIS cascade on neurodegeneration in a C. elegans model of excitotoxicity, where a mutation in a central Glu transporter (glt-3) in a sensitizing background causes Glu-Receptor -dependent neuronal necrosis. We expand our studies on the role of the IIS cascade in determining susceptibility to excitotoxic necrosis by either blocking IIS at the level of PI3K/AGE-1 or stimulating it by removing the inhibitory effect of ZFP-1 on the expression of PDK-1. We further show that the components of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex, known to regulate PIP2 production and the IIS cascade, modulate nematode excitotoxicity: mutations that are expected to reduce the complex's ability to produce PIP2 and inhibit the IIS cascade protect from excitotoxicity, while overstimulation of PIP2 production enhances neurodegeneration. Our observations therefore affirm the importance of the IIS cascade in determining the susceptibility to necrotic neurodegeneration in nematode excitotoxicity, and demonstrate the ability of Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex to modulate neuroprotection.

Indexed as

ApoptosisSignal TransductionAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGuanine Nucleotide Exchange FactorsInsulinNecrosisNeuronsPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)SomatomedinsTranscription FactorsAGE-1 protein, C elegansCaenorhabditis elegans Proteinscytohesin-1Guanine Nucleotide Exchange FactorsInsulinPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Ppk-1 protein, C elegansSomatomedinsTranscription FactorsZfp-1 protein, C elegans

Identifiers

PMID25422944
PMCPMC4244091
OpenAlexW2052113027

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.